Disease modifying activity of HWA 486 on the development of SLE in MRL/1-mice.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000188:drug therapy*; D007555:Isoxazoles / Q000627:therapeutic use*; D000077339:Leflunomide; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D051379:Mice; D008815:Mice, Inbred Strains; D010080:Oxazoles / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D007555:Isoxazoles; D010080:Oxazoles; D000077339:Leflunomide